BSE filing, BSE: 544312. Summary written from the filing by ALFA Finder's alert engine.
Hamps Bio Ltd: key numbers
- Share price
- ₹25.50
- Market cap
- ₹22.22 Cr
- Revenue (annual)
- ₹8.47 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -30.1×Sector 26.2×
- Promoter holding
- 71.99%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hamps Bio Ltd
All →Hamps Bio Other Announcement
Hamps Bio Ltd submitted a Regulation 74(5) certificate from its RTA. The certificate confirms the company's shares are held entirely in demat form.
Hamps Bio Board Meeting Outcome
Hamps Bio Ltd announced the board meeting outcome, approving revised remuneration for its Chairman & Managing Director, Whole Time Director, CFO, and a Director.
Hamps Bio Annual General Meeting
Hamps Bio Ltd held its 19th Annual General Meeting on September 09, 2026, where shareholders transacted the businesses mentioned in the AGM notice.
Hamps Bio Annual Report
Hamps Bio Ltd has submitted its Annual Report for the financial year 2025-26. The report includes the notice of the 19th Annual General Meeting.
Hamps Bio Annual General Meeting
Hamps Bio Ltd has issued a notice for its 19th Annual General Meeting to be held on September 09, 2026.
Hamps Bio Other Announcement
Hamps Bio Ltd updated stock exchange contact details for its Key Managerial Personnel. This is a routine compliance filing under SEBI LODR Regulation 30(5).
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.